Fast-developing consumerism in China is giving us a glimpse as to what is working and what could shape our future commerce habits worldwide. Currently, the mobile and social revolutions are taking over the commerce world, a process that is expected to accelerate.

According to Statista (http://nnw.fm/ottB9), the number of smartphone users is expected to go from 2.1 billion in 2016 to 2.87 billion by the end of 2020, leading to a potentially huge surge in the number of consumers shopping on their phones. Most importantly, this sector is being led by China, which CNBC says accounts for approximately 30% of the global smartphone market and holds mobile commerce far more sophisticated and advanced than that of other countries (http://nnw.fm/7tT9d). Aside from the fact that nearly two-thirds of retail and consumer-to-consumer e-commerce sales in the fourth quarter of 2015 were made on mobile in China (http://nnw.fm/TYV0s), the country is also far more advanced in terms of mobile money transfers; loyalty programs such as vouchers, coupons, and e-ticketing; delivery systems; and content purchasing.

E-commerce is not the only area of marketing that China is influencing. The country is known for integrating its e-commerce with social media. Social commerce has not only allowed for the proliferation of the online-to-offline (O2O) world but has also become a way to facilitate better customer relationship management (CRM) and, of course, commerce. Companies are now able to have personalized, one-on-one interactions with customers, thus making more sales.

In China, sophisticated social marketing platforms such as those designed by Moxian, Inc. (NASDAQ: MOXC) are fueling this constant growth, and the competitive market there is pushing Moxian to continue its innovation. The company’s mobile applications, Moxian+ User and Moxian+ Business, act as one-stop shops for both mobile shoppers and businesses, linking them together seamlessly with a variety of features and technology.

The Moxian+ User application incorporates social networking with gaming, using the company’s virtual currency whereby users can redeem prizes sponsored by Moxian and Moxian merchants. On the other hand, the Moxian+ Business application is a social CRM tool that not only allows business to set up shop on the Moxian platforms but also pushes promotions to users, all while generating reports giving them a 360-degree view of their progress on the Moxian platform.

For more information, visit www.Moxian.com

With 2.3 million listings and a valuation of more than $30 billion, Airbnb has become the behemoth of the alternative lodging rental (ALR) industry. Concocted 10 years ago to supplement rent, the idea of renting lodging from private home owners has taken off and turned the travel industry on its head. Renting a room or an entire house has gained widespread public acceptance. By providing vacationers with better options and home owners with newfound income, high-margin revenues can be generated by the intermediary. Naturally, this mutually beneficial arrangement for owners and renters has spurred competition in the alternative lodging rental arena. Multiple companies now offer varying forms of online alternative lodging rentals. The ALR market has proven to be so large and lucrative that the owner of one of the world’s largest travel websites, Expedia, acquired HomeAway’s ALR platform for $3.9 billion in 2015.

Even with large valuations for the companies, traditional ALR booking has drawbacks for travelers. Ongoing irritants include the need to employ multiple sites to arrange lodging, airlines, cruises, concierge services, and rental cars. Delayed lodging and travel confirmation is also a continuing source of consternation with travelers trying to book vacation packages. Often taking days or even weeks, travelers can’t even start to arrange for transportation or other services until after confirmation of lodging. In spite of this quandary, most ALR sites require users to fend for themselves when trying to create and book a comprehensive vacation itinerary.

The stand-out strength of Monaker Group (OTCQB: MKGI) is that it has managed to eliminate these irritants and delays. Monaker now offers a first in the ALR market: instant confirmation for ALR booking. Monaker Group’s unique ALR platform offers these services through its innovative, real-time booking platform NextTrip.com. The company then brings this unmatched new tool into the mainstream travel industry, merging it with conventional travel bookings, so that NextTrip.com is the only platform to offer travelers real-time ALR booking plus access to all the other conventional travel and lodging options needed to plan and organize vacations. There’s nothing else like it.

A technology driven, comprehensive travel company, Monaker Group utilizes multiple divisions and brands, leveraging its more than 60 years of operation in leisure travel, to serve the tourism industry. Decades of experience have given Monaker invaluable insights into how to best serve today’s traveler. On the high end, the company provides highly customizable tours, escorted vacations and travel solutions through its Maupintour subsidiary. Monaker’s Extraordinary Vacations Group (EXVG) platform will soon exploit a largely untapped market by providing timeshare owners the ability to market their unused timeshare, fractional, condo-hotel units to travelers, while the company’s Voyage TV division, with thousands of hours of worldwide travel footage, is utilized to enhance and market travel services across all of the company’s brands.

In the large and lucrative ALR market, Monaker’s real-time booking innovations and comprehensive one-stop services have given Monaker a new and unique position in the travel industry.

For more information, visit www.MonakerGroup.com

Digital services have now transformed traditional markets across the world. Businesses and individuals alike expect to be able to use digital services in a variety of contexts, on multiple devices, through various channels. Despite this growing trend, statistics from Progress.com (http://nnw.fm/1DfaT) show that, although many companies are developing their strategies for digital transformation, they do not plan to execute these strategies in the coming year. In addition, 2016 data showed that more than 40% of companies haven’t even started their digital transformation. This lack of adoption can be attributed to these companies’ management teams not knowing how to monetize their digital services and goods, or even a fear of simply being too late.

The first step organizations need to take is to focus their attention on “revenue moments”. Revenue moments can happen whenever customers interact with a company through a digital platform such as a website, social media pages, email campaigns, products, or other business channels. In order to transform these revenue moments into actual revenue, businesses must implement the appropriate payment tools that are most likely to speak to their customers.

Net Element, Inc. (NASDAQ: NETE), a globally recognized payment technology company, specializes in mobile payments and value-added transaction services. Through its subsidiary, Digital Provider, the company offers a large portfolio of customizable payment solutions that enable organizations to monetize their goods and increase conversions.

In addition to the trending mobile payment solutions, Digital Provider offers mobile marketing opportunities and shortcode rentals, a tool used to simplify the pattern of interaction between customers that visit a business’ online store and all other online services. These services are coupled with call center rentals, automated mass payments, and a package solution giving organizations the chance to fundraise for charity.

For more information, visit the company’s website at www.NetElement.com

It was in the 1980s that American households first heard about HIV, the virus that causes AIDS. Since the HIV epidemic began in the 1980s, the virus has continued to affect millions around the world—including more than 1.2 million people in the United States who are currently living with HIV. Of those 1.2 million-plus individuals, one in eight doesn’t even know they have HIV, according to the Centers for Disease Control and Prevention (http://nnw.fm/n7Z9t).

Over the years, many advancements have been made in the treatment of HIV, but, clearly, there are still strides to be made in fighting this devastating virus and preventing the havoc it wreaks on the human immune system.

Many doctors currently prescribe multi-drug combination therapy to HIV patients in an effort to avoid HIV cell mutation and the development of single-therapy resistance. The following classes of antiretroviral drugs are currently approved by the U.S. Food and Drug Administration to treat HIV and AIDS (http://nnw.fm/rLO6w):

• Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
• Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
• Protease Inhibitors (PIs)
• Fusion Inhibitors
• Entry Inhibitors – CCR5 co-receptor antagonist
• HIV integrase strand transfer inhibitors

The advent of highly active antiretroviral therapy (HAART) has made HIV-1 infection manageable as a chronic disease for patients with access to treatment and who achieve durable virologic suppression, but there is more to be done.

One biotechnology company, CytoDyn Inc. (OTCQB: CYDY), currently stands out for its pioneering efforts to develop humanized monoclonal antibodies to treat HIV infection with many advantages over current standard of care.

CytoDyn’s lead product, PRO 140, is the first self-administered antibody therapy for HIV in late-stage clinical trials and addresses the primary reasons for failings of HAART, such as side effects, toxicity, drug resistance and compliance issues. In 200 patients involved in more than seven clinical trials, PRO 140 has demonstrated only minor side effects with hardly any toxicity. Further, no drug resistance, no serious adverse effects and no negative impact on immune function have been evidenced. Because PRO 140 is administered via once-weekly, self-administered subcutaneous injection, compliance issues are also improved in comparison to HAART.

Not only is PRO 140 one of the most advanced experimental monoclonal antibodies for the treatment of HIV, it is believed that PRO 140 will help patients with complicating issues, including single- or multi-drug resistance, intolerance to currently available therapies due to toxicity and side effects, and complex medical needs or compromised organ function.

PRO 140 is part of a new class of HIV/AIDS therapeutics called viral-entry inhibitors that are intended to protect healthy cells from being infected. This humanized monoclonal antibody binds to CCR5, which is the HIV entry receptor, and blocks HIV entry into white blood cells.

PRO 140 is currently being evaluated in combination with HAART (in a pivotal, Phase 2b/3 trial) and as an alternative to HAART (in a Phase 2b/3 monotherapy trial). There are also pipeline opportunities for non-HIV indications for PRO 140, including transplantation, autoimmunity, cancer and chronic inflammation.

For more information, visit www.CytoDyn.com

At first blush, India Globalization Capital (NYSE: IGC) would seem a curiosity clothed in an enigma. Just how does a NYSE company move from a successful mining orientation to a pioneer in the development of multiple cannabinoid-based pharmaceutical therapies to treat pain and disease? The enigma can be disrobed by looking at the tenacity and vision of its management.

Ram Mukunda has served as Executive Chairman, CEO and President of India Global since inception in 2005. He holds distinguished mathematics and engineering degrees and worked in multiple Wall Street positions for more than 25 years, serving communications firms such as Intelsat SA and Startec. Mukunda actually founded Startec in 1991 to provide VOIP service to emerging economies. As Chairman and CEO of Startec, he led the company to a $60 million public stock offering in 1997. His introduction to the mining industry came a few years later through a company he co-founded, India Globalization Capital. The company mined and converted low-grade iron ore to high-grade ore. Iron ore prices subsequently plummeted nearly 75 percent, putting it below the cost of production. That’s when Mukunda made a difficult decision and charted a course change for the company.

Realizing that the lucrative mining business was bust, he searched for a growth arena to position the company and move forward. He ultimately centered on the burgeoning cannabis industry and the myriad of potential medical benefits. Mukunda and his team realized that there were a lot of untapped uses for cannabinoids and cannabis-based extracts. They recruited a team of highly skilled doctors and patent attorneys, comparing anecdotal stories with scientific evidence and identifying areas where patents had not been filed. This process has yielded results.

The company now has a pipeline of patent pending cannabinoid-based drugs targeting large market maladies, which includes therapeutics for neuropathic pain, human and animal seizures, refractory epilepsy and eating disorders. Several of these therapeutic drugs are scheduled for pre-clinical trials this year. The company is transitioning fast from building research teams and developing a patent portfolio to marketable products.

For the past few years, India Globalization Capital has also focused interest on cannabis-based combination therapies, using cannabis-based extracts in combination with other medications to reduce side effects and increase bioavailability and absorption. As one of the first to enter this space, the company has been building intellectual property around these precepts and expects to reap substantial rewards from this arena.

From mining to medical marijuana would seem an incredible leap, but, when looking at India Global and the leadership of Ram Mukunda, it would be tough to bet against a leader with such tenacity and vision. And with a $12MM market cap, IGC is quite compelling given the valuations attributed to its peers.

For more information, visit the company’s website at www.IGCinc.us

Let us hear your thoughts: India Globalization Capital, Inc. Message Board

Exocrine Pancreatic Insufficiency, or EPI, is a problem in a person’s digestive system. Simply put, EPI is when the pancreas cannot produce enough of the enzymes that the body requires to break down and absorb nutrients. Unfortunately, this means that the body is unable to absorb the right fats and nutrients, often leading to weight loss.

There are a number of causes for EPI, such as inflammation of the pancreas; effects from surgery on the pancreas, intestines, or stomach; or even an inherited disease such as cystic fibrosis, Shwachman-Diamond syndrome, Crohn’s Disease, diabetes, or celiac disease. Symptoms do vary, but normally the patient will feel a pain or tenderness in the abdomen, problems with bowel movements, flatulence, and a feeling of being full.

Today, there has been a rise in the number of people with EPI, and this has been largely attributed to an increase in the number of patients diagnosed with diabetes and cystic fibrosis (CF). According to an article from PR Newswire (http://dtn.fm/uyF9L), there are approximately 70,000 people living with cystic fibrosis worldwide, with 1,000 new cases diagnosed each year. In addition, 50% of children with CF suffer from EPI from the moment they are born.

According to TransparencyMarketReserarch.com (http://dtn.fm/0tvSc), the EPI market is growing at an astronomical rate, and this is not expected to slow, since the number of patients diagnosed with diabetes is expected to grow to approximately 366 million by the end of 2030. PR Newswire reported an anticipated expansion of the market at a CAGR of over 8% between 2015 and 2023, allowing it to reach just under $3 billion.

Unfortunately, despite the expected market growth, current EPI treatments have a number of limitations. Aside from a healthy diet, the current treatment for EPI is Pancreatic Enzyme Replacement Therapy (PERT), but not only are these treatments not very effective, they also show a lack of stability in an acidic environment and carry a high pill burden, which can be highly inconvenient for patients.

Luckily, AzurRx BioPharma, Inc. (NASDAQ: AZRX), a development stage biopharmaceutical company focused on creating treatments for patients suffering from gastrointestinal diseases such as EPI, is currently in Phase IIa of the development of MS1819 lipase, a non-systemic, yeast-derived recombinant enzyme.

This orally-administered capsule is not only showing significant potential for the treatment of EPI in patients with chronic pancreatitis and cystic fibrosis; it is also demonstrating activity in long chain fats and stability in protease and bile salt environments. MS1819 lipase could give patients suffering from EPI the chance to reduce their pill burden from 25 to 40 pills a day to as little as five to eight.

For more information, visit the company’s website at www.AzurRx.com

Construction and demolition (C&D) materials represent the debris from the demolition, construction, or renovation of buildings, bridges, or even roads. C&D materials are normally heavy materials such as concrete, wood, asphalt, gypsum, bricks, glass, some types of plastic, salvaged building components, metals and trees, among other materials.

In the United States, C&D materials constitute a large percentage of waste, much of which can be transformed into new productive products. According to a report entitled ‘Advancing Sustainable Materials Management: 2014 Fact Sheet’ (http://dtn.fm/HiA4r), over 500 million tons of C&D debris were generated in 2014, with concrete making up 70% of it, asphalt 14%, wood more than 7%, and other products making up approximately 9% between them.

All the materials outlined above can either be reduced, salvaged, recycled, or reused by simply preserving existing buildings rather than constructing new ones, designing new buildings that can be adapted to make them last longer, establishing construction methods that allow for the disassembly and reuse of materials, using different framing techniques, and reducing the various types of interior finishes.

In addition, steps are being taken by companies such as National Waste Management Holdings, Inc. (OTC: NWMH) to reduce the impact C&D has on the environment. NWMH is a solid waste management company located in Central Florida.

The company is focused on operating according to an eco-friendly business model that has been put in place to combat unnecessary waste in Florida and New York. To pursue its mission of being environmentally conscience with a focus on sustainability, NWMH is committed to inspecting all loads and sorting all the materials that arrive in its landfills in order to accept only those that are compliant with the C&D Department of Environmental Protection standards.

In addition to the company’s high level of compliance with the Department of Environmental Protection (DEP), National Waste Management plans on using its picking station to aid the state of Florida in its quest to meet its mandate for 75% recycling by the end of 2020. This incentive will give the company the ability to increase its rate of recyclables and sales of commodities.

For more information, visit the company’s website at www.nationalwastemgmt.com

Let us hear your thoughts: National Waste Management Holdings, Inc. Message Board

When Harvard professor Clayton Christensen coined the term ‘disruptive innovation’, he had in mind technologies like the one being developed by MGX Minerals, Inc. (OTC: MGXMF) (CSE: XMG) (FRA: 1MG). This innovative company is poised to ignite a revolution in the energy sector with technology that extracts lithium from oil and gas wells. Its PetroLithium™ methodology separates valuable minerals from the salt water that typically accompanies crude oil, offering a novel way to extract lithium, an essential ingredient in the batteries of our laptops, mobile phones, and other electronic devices and, increasingly, our cars. As MGX refines its technology, it is quickly acquiring oil and gas properties, and operation of its initial Petrolithium™ borehole well is set to commence soon.

In an Emerging Theme Radar report (http://dtn.fm/ZW8b8), Goldman Sachs (GS) called lithium the ‘new gasoline’, saying its ‘unique properties make it a key enabler of the electric vehicle revolution’. Advances in battery technologies and a growing desire to avoid the hazards of fossil fuels signal a period of sustained growth for electric vehicles, which are forecast to rise from their present three percent of the automobile market to a penetration of 22 percent by 2025. Current demand for lithium runs to about 160,000 metric tons. According to GS, ‘a one-percent increase in battery electric vehicle penetration would increase lithium demand by 70,000 metric tons of lithium carbonate equivalent (LCE) annually (or roughly half of current global demand for lithium).’

Lithium carbonate occurs in the salt water (brine) that accompanies petroleum (crude oil) as it’s pumped to the surface. However, petroleum brine, like gas in the early oil industry, has been treated as a waste product, and it’s either injected deep underground or stored in giant tanks after it is separated from the oil. These traditional disposal methods have resulted in environmental damage: polluting potable water supplies and causing landslides.

The PetroLithium™ process, consequently, holds the promise of killing two birds with one stone: extracting a valuable resource from material that would go to waste while offering a safer way to dispose of that waste. Extracting lithium from petroleum brine is also faster and less costly than conventional methods, like solar evaporation and hard-rock mining. In a recovery process specifically designed for the highly mineralized brine associated with petroleum, lithium brine evaporation times are expected to fall to less than one day. Traditional solar evaporation techniques take up to 18 months.

In early March, MGX reported encouraging results for tests on its latest petrolithium methodology. The extraction process was able to concentrate lithium more than 20-fold while removing contaminants in a low-energy process. Solutions of 67 mg lithium per liter of petroleum brine were concentrated to 1,600 mg lithium per liter.

MGX has significantly expanded its Alberta petrolithium portfolio through the acquisition of additional metallic and industrial mineral permits covering over 133,000 hectares, and it has acquired an additional 301 mineral claims encompassing 6,020 acres within the Paradox basin of southeastern Utah. The new claims further increase the company’s Lisbon Valley land package to 23,780 acres. The Lisbon Valley oil and gas field is located approximately 40 miles southeast of Moab, Utah, in the salt anticline belt on the southwest edge of the Paradox Basin in San Juan County. Historic lithium brine content there has been reported as high as 730 parts per million of lithium.

Last week, MGX announced it had entered into a joint operating agreement with a private vendor to act as operator and acquire a 75 percent working interest in certain oil and gas leases located contiguous to the company’s Lisbon Valley petrolithium project. Preparations to permit the petrolithium #1 borehole well will commence upon closing of the agreement.

MGX is offering a win-win combo with its PetroLithium™ technology, which promises a faster, less expensive method of lithium extraction, while disposing of oil and gas production waste in an environmentally friendly way. The company is a diversified mining company engaged in the development of large-scale industrial mineral portfolios in western Canada and the United States. MGX operates lithium, magnesium and silicon projects throughout British Columbia and Alberta, as well as petrolithium exploration in Utah.

For more information, visit the company’s website at www.MGXMinerals.com

Let us hear your thoughts: MGX Minerals, Inc. Message Board

ProBility Media Corp.’s (OTCQB: PBYA) acquisition of One Exam Prep LLC, which was completed earlier this year, is key to its growth strategy. One Exam Prep is currently specializing in exam preparation and certification in the construction industry. It offers continuing education and certification online or in a classroom setting in 20 states, with the goal of operating in all 50 states. ProBility Media reported revenue at greater than $1 million for Q1 ended January 31, 2017.

Houston-based ProBility is an EdTech company serving 15 vertical categories in more than 60 skilled trades. It is positioned as an industrial training resource for individuals and small businesses. It offers training services as well as materials for education, advancement in careers, and testing. Virtual reality training, now operational for the crane business, will be expanded into other industries. The company said it is also beginning to investigate international expansion.

One Exam Prep, based in Coconut Creek, Florida, offers low cost yet effective exam prep courses in the construction industry. The company owns more than 70 domains related to contractor licensing and continuing education, according to One Exam’s Rob Estell, and it has created hundreds of courses offered either online or in traditional classroom settings in more than 20 states.

For the three months ended January 31, 2017, ProBility Media recorded revenues of $1,088,180, compared to $878,005 during the same period of the prior year. The recent three-month sales total represented the company’s third consecutive quarter of year-over-year revenue growth. The results of One Exam are included in the consolidated financial performance, subsequent to January 1, 2017.

ProBility Media entered into a multi-year consulting agreement with Rob Estell, the founder of One Exam, through December 31, 2020. It includes salary, an annual performance bonus based on One Exam’s revenues and profits, a signing payment, and a non-recourse secured convertible promissory note valued at $300,000.

For more information, visit the company’s website at www.ProBilityMedia.com

Let us hear your thoughts: ProBility Media Corp. Message Board

The legalization of cannabis across many states in the U.S. has opened doors to various innovators, leaving the tech world to rapidly adapt to this trending industry. There’s now a strong move by cannabis-oriented businesses to incorporate common technologies found in other industries, and such innovations are not just found in dispensaries. Improvements are being made on the technology surrounding the agricultural, marketing, production, and distribution channels in the marijuana market. Technology is also being used to solve challenging issues such as payment options.

Singlepoint, Inc. (OTC: SING), a publicly traded holding company, offers payment solutions to the cannabis industry through its SingleSeed subsidiary. The company offers noncash payment solutions to marijuana businesses that are legal, easy to use, and safer for both the companies using them and the customers purchasing products. However, it is not just through payment solutions that Singlepoint is sparking innovation in the cannabis technology market.

Recently, Singlepoint has made public its plan to undertake strategic acquisitions of companies that are in the cannabis industry but which do not in any way touch the plant itself. As the marijuana market in the U.S. continues to flourish, this strategy has started to unfold with SING’s acquisition of a stake in Convectium, a company that has created a unique machine that fills and packages vape cartridges and disposable vape pens at a rate of 100 per 30 seconds.

In a recent interview with Donald Baillargeon from MoneyTV (http://dtn.fm/OCAe3), Greg Lambrecht, CEO of Singlepoint, announced that the company has provided its initial round of funding to Convectium, where demand and sales have soared for this quarter compared to the same quarter of 2016. According to Lambrecht, the Convectium product is a perfect acquisition for Singlepoint, not only because of its in-demand capabilities, but because it does not require direct involvement with the plant and, therefore, does not break any state or federal regulations.

According to Lambrecht, Singlepoint has entered into an independent sales agreement with Convectium, whereby Singlepoint will be selling the machine in order to increase its revenues. He continued to emphasize the greatness of both Convectium and its product during the interview, highlighting the fact that comparative financial results of 2016 and 2017 will soon be released.

With the legal cannabis market projected to grow at a compound annual rate of 17%, according to Forbes (http://dtn.fm/UmNX8), Singlepoint aims to focus its attention on cannabis enterprises rather than cultivation, allowing it to aid investors in the cannabis market to diversify their portfolios through equipment providers and consumer product makers. Despite marijuana still being classified as a Schedule 1 drug, Singlepoint is making strides in the cannabis technology market and plans to continue to diversify its revenue streams within the industry.

For more information, visit the company’s website at www.Singlepoint.com

Let us hear your thoughts: Singlepoint, Inc. Message Board